Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-029962

Chief Executive Officer gave up 741 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-01 Shares withheld for taxes : show line 1 in the form −741 $38.33 $28,403 145,790 D
Loading xslF345X03/doc4.xml…